Sign In
Last checked at 
14 Jul 2022 12:33
14 July 2022
DR. MARTENS PLC
RESULT OF ANNUAL GENERAL MEETING
14 JULY 2022
The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.
Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16 to 19 as Special Resolutions.
Resolution
| VotesFor
| %
| Votes Against
| %
| VotesTotal
| Votes Withheld
| % Voting Capital Instructed | |
01 | Receive the 2022 Annual Report and Accounts | 813,848,188 | 100.00 | 0 | 0.00 | 813,848,188 | 783,563 | 81.36% |
02 | Approve the Directors' Remuneration Report | 807,707,382 | 99.15 | 6,923,259 | 0.85 | 814,630,641 | 1,110 | 81.44% |
03 | Approve the Final Dividend | 811,746,252 | 99.65 | 2,885,099 | 0.35 | 814,631,351 | 400 | 81.44% |
04 | Re-elect Paul Mason | 798,851,082 | 98.70 | 10,553,833 | 1.30 | 809,404,915 | 5,226,836 | 80.92% |
05 | Re-elect Kenny Wilson | 809,826,477 | 99.41 | 4,804,764 | 0.59 | 814,631,241 | 510 | 81.44% |
06 | Re-elect Jon Mortimore | 809,094,165 | 99.32 | 5,537,076 | 0.68 | 814,631,241 | 510 | 81.44% |
07 | Re-elect Ian Rogers | 810,551,309 | 99.50 | 4,079,932 | 0.50 | 814,631,241 | 510 | 81.44% |
08 | Re-elect Ije Nwokorie | 809,887,078 | 99.42 | 4,744,163 | 0.58 | 814,631,241 | 510 | 81.44% |
09 | Re-elect Lynne Weedall | 791,704,376 | 97.19 | 22,926,665 | 2.81 | 814,631,041 | 710 | 81.44% |
10 | Re-elect Robyn Perriss | 803,176,287 | 98.59 | 11,454,954 | 1.41 | 814,631,241 | 510 | 81.44% |
11 | Re-elect Tara Alhadeff | 804,121,618 | 98.71 | 10,509,623 | 1.29 | 814,631,241 | 510 | 81.44% |
12 | Appoint PricewaterhouseCoopers LLP as auditor | 813,775,770 | 99.89 | 855,681 | 0.11 | 814,631,451 | 300 | 81.44% |
13 | Authorise the Audit & Risk Committee to determine the Auditor's remuneration | 814,220,813 | 99.95 | 410,638 | 0.05 | 814,631,451 | 300 | 81.44% |
14 | Authorise the Company and its subsidiaries to make political donations | 809,153,872 | 99.33 | 5,476,763 | 0.67 | 814,630,635 | 1,116 | 81.44% |
15 | Authorise allotment of shares | 797,319,899 | 97.87 | 17,311,344 | 2.13 | 814,631,243 | 508 | 81.44% |
16 | Authorise general disapplication of pre-emption rights* | 813,947,595 | 99.92 | 683,756 | 0.08 | 814,631,351 | 400 | 81.44% |
17 | Authorise additional disapplication of pre-emption rights* | 811,886,184 | 99.66 | 2,745,167 | 0.34 | 814,631,351 | 400 | 81.44% |
18 | Authorise purchase of own shares* | 813,899,052 | 99.95 | 446,465 | 0.05 | 814,345,517 | 286,234 | 81.41% |
19 | Authorise calling of general meetings on 14 days' notice* | 795,268,484 | 97.62 | 19,362,867 | 2.38 | 814,631,351 | 400 | 81.44% |
*Special Resolution
The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:
Resolution
| VotesFor
| %
| Votes Against
| %
| VotesTotal
| Votes Withheld
| % Independent Capital Instructed | |
07 | Re-elect Ian Rogers | 440,608,869 | 99.08 | 4,079,932 | 0.92 | 444,688,801 | 510 | 70.55% |
08 | Re-elect Ije Nwokorie | 439,944,638 | 98.93 | 4,744,163 | 1.07 | 444,688,801 | 510 | 70.55% |
09 | Re-elect Lynne Weedall | 421,761,936 | 94.84 | 22,926,665 | 5.16 | 444,688,601 | 710 | 70.55% |
10 | Re-elect Robyn Perriss | 433,233,847 | 97.42 | 11,454,954 | 2.58 | 444,688,801 | 510 | 70.55% |
Notes:
1. Votes "For" and "Against" are expressed as a percentage of votes received.
2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
3. As at 6.30pm on 12 July 2022 the Company had a total of 1,000,283,652 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 7-10, was 630,341,212.
4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
Investors and analysts
Mark Blythman, Interim Director of Investor Relations +44 7570 871207mark.blythman@drmartens.com
Media
Gill Hammond, Director of Communications +44 7384 214248
Maitland +44 20 7379 5151Clinton Manning +44 7711 972 662Joanna Davidson +44 7827 254 567
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.
Follow the stocks
